Science & Enterprise subscription

Follow us on Twitter

  • A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from e… https://t.co/CvnMEFT0Cm
    about 8 hours ago
  • New post on Science and Enterprise: Start-Up Developing Engineered B-Cell Therapies https://t.co/vMgdwnIXdi #Science #Business
    about 8 hours ago
  • Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a ora… https://t.co/e2d7m6HG1E
    about 11 hours ago
  • New post on Science and Enterprise: Roche Gains Covid-19 Oral Drug Candidate https://t.co/nh27g6uCwi #Science #Business
    about 11 hours ago
  • The day that America lost $100 billion because of an immigration visa ban https://t.co/OfEx6SFwxA via @BrookingsInst
    about 1 day ago

Please share Science & Enterprise

Start-Up Developing Engineered B-Cell Therapies

Human B-cell

A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from engineered B-cells in the immune system. . . . → Read More: Start-Up Developing Engineered B-Cell Therapies

Roche Gains Covid-19 Oral Drug Candidate

Pills and capsules

Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a oral drug, rather than an infusion. . . . → Read More: Roche Gains Covid-19 Oral Drug Candidate

Carb-X Funding Nanoscale Sponge to Treat Sepsis

Hospital room

A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment. . . . → Read More: Carb-X Funding Nanoscale Sponge to Treat Sepsis

Software Designed to Model, Visualize Brain Circuits

NetPyNE GUI screen

An academic-industry team designed a web-based software tool to ease the computer modeling, simulation, and visualization of the brain’s nerve cell circuits. . . . → Read More: Software Designed to Model, Visualize Brain Circuits

Covid-19 Vaccine Challenge Trial Underway

Syrine ingloved hand

Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines. . . . → Read More: Covid-19 Vaccine Challenge Trial Underway

Myeloma Drug Shown to Treat Covid-19 Patients

Sea squirt

Results from an early clinical trial show a drug designed to treat multiple myeloma also reduces viral loads and hospital stays of patients with Covid-19 infections. . . . → Read More: Myeloma Drug Shown to Treat Covid-19 Patients

ALS Drug Shown to Extend Patient Survival

Motorized wheelchair

Results of a clinical trial show a drug to treat amyotrophic lateral sclerosis, or ALS, extends patients’ survival by several months and slows decline of their functions. . . . → Read More: ALS Drug Shown to Extend Patient Survival

Lilly Gains Neuro Disease Biotech in $1.36B Deal

Nerve cells illustration

Drug maker Eli Lilly and Co. is acquiring Disarm Therapeutics, a biotechnology company developing treatments for neurodegenerative disorders. . . . → Read More: Lilly Gains Neuro Disease Biotech in $1.36B Deal

Cancer Center, Biotech Partner on Off-the-Shelf T-Cells

T-cells and cancer cells

MD Anderson Cancer Center and Allogene Therapeutics Inc. agreed to jointly study the company’s cancer treatments derived from donated T-cells. . . . → Read More: Cancer Center, Biotech Partner on Off-the-Shelf T-Cells

Blood Test Shown to Predict Covid-19 Symptom Severity

Blood vials

A blood test that measures the ratio of two key immune system proteins is shown in tests with patients to predict the severity of Covid-19 symptoms. . . . → Read More: Blood Test Shown to Predict Covid-19 Symptom Severity